May 20, 2011

Company seeks to end needle pain in dentistry

FORT COLLINS – St. Renatus CEO Steve Merrick is spending a lot of time on the road these days, seeking to interest potential investors in a new drug that he says will revolutionize dentistry.

The Fort Collins-based startup is working to get final FDA approval for “the world’s first needle-free dental anesthetic administered through the nasal cavity,” according to the St. Renatus website.

That’s right – a dental anesthetic that’s misted into the nose.

And that’s something many needle-fearing adults and probably most kids would be very interested in trying when they sit down in that dentist’s chair, Merrick said.

“When this drug is…

Categories:
Sign up for BizWest Daily Alerts
Closing in 8 seconds...